SILTRAX EPI NO. 9
Natural health product licensed in Canada
- Licence holder
- Pascal International Corporation
- NPN or DIN-HM
- 02097745
- Status
- Active licence
- Licence date
- 10 October 2007
- Revision date
- Not provided
- Form
- Ficelle
- Route of administration
- Dentaire
- Application type
- DIN de transition
Oral dose analysis does not apply without an established exclusively oral route.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Sodium Bisulfite, Hydroxyde d'ammonium, Sodium Dithionite, Sodium Thiosulphate, anhydrous, éthanol anhydre, Acide phosphorique, Phosphate de sodium, monobasique, Chlorure de sodium, Eau purifiée, alcool benzylique, Chlorure de zinc
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 cord | Not specified |
| Enfants | Not specified | 1 cord | Not specified |
Uses authorised in Canada
Use whenever gingival retraction is advisable in dental practice; as preceding impression taking with any elastic impression material; or prior to placement of caps, crowns, bridges, etc. SIL-TRAX (R) EPI is braided cotton cord saturated with a solution of Racemic epinephrine hydrochloride dried by a technique which retains the activity of the medication. Normal tissue moisture reactivates the medication, which promptly retracts gingival tissue in a manner that causes no tissue damage, yet fully exposes the gingival margin.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 02097745
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.